InvestorsHub Logo

mick

05/16/20 12:38 PM

#232 RE: mick #231

Science Behind Serlopitant
Serlopitant, a highly selective, once-daily, oral small molecule inhibitor of the neurokinin 1 receptor, or NK1R, is an investigational drug that acts through a novel mechanism to potentially alleviate pruritus associated with various conditions.

LEARN MORE

tdeck

05/17/20 11:55 AM

#237 RE: mick #231

Who cares what Piper Sandler said about Menlo? I will se you fools in December.

Others, use the hustle these people play to your benefit, play the channel they provide to flip 25% of your position to build size to your position, leaving the other 75% at GTC orders $5+

The game is already won, its just a case of finding out the final score.

Peace out.

Use the small money nitwits to your advantage. I do it every day, day in and day out.